arrow
Back
R

Rebecca Johnson

Harvard Medical School

5H-index
24Paper Count
374Citation Count
Published Papers 6
Publication Date
Real-World Outcomes of Adjuvant Therapy in Stage III Melanoma and the Impact of Somatic Mutations
err2025-12-04
err0
errOAAI
errEffiom, Derek; Aprati, Tyler; Karneris, Anastasios; Lawless, Aleigha; Sharova, Tatyana; Johnson, Rebecca; Menzies, Alexander; Long, Georgina; Park, Benjamin; Jung, Seungyeon; Johnson, Douglas; Liu, David; Bai, Xue; Flaherty, Keith; Sullivan, Ryan; Boland, Genevieve M.; Cohen, Sonia
errShare
errSave
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after de fi nitive surgery: a multicenter, retrospective cohort study (vol 65, 102290, 2023)
err2024-05-01
err0
errOAAI
errBai, Xue; Shaheen, Ahmed; Grieco, Charlotte; Arienzo, Paolo D.; Mina, Florentia; Czapla, Juliane A.; Lawless, Aleigha R.; Bongiovanni, Eleonora; Santaniello, Umberto; Zappi, Helena; Dulak, Dominika; Williamson, Andrew; Lee, Rebecca; Gupta, Avinash; Li, Caili; Si, Lu; Ubaldi, Martina; Yamazaki, Naoya; Ogata, Dai; Johnson, Rebecca; Park, Benjamin C.; Jung, Seungyeon; Madonna, Gabriele; Hochherz, Juliane; Umeda, Yoshiyasu; Nakamura, Yasuhiro; Gebhardt, Christoffer; Festino, Lucia; Capone, Mariaelena; Ascierto, Paolo Antonio; Johnson, Douglas B.; Lo, Serigne N.; V. Long, Georgina; Menzies, Alexander M.; Namikawa, Kenjiro; Mandala, Mario; Guo, Jun; Lorigan, Paul; Najjar, Yana G.; Haydon, Andrew; Quaglino, Pietro; Boland, Genevieve M.; Sullivan, Ryan J.; Furness, Andrew J. S.; Plummer, Ruth; Flaherty, Keith T.
errShare
errSave
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study
err2023-11-01
err7
errOAAI
errBai, Xue; Shaheen, Ahmed; Grieco, Charlotte; d'Arienzo, Paolo D.; Mina, Florentia; Czapla, Juliane A.; Lawless, Aleigha R.; Bongiovanni, Eleonora; Santaniello, Umberto; Zappi, Helena; Dulak, Dominika; Williamson, Andrew; Lee, Rebecca; Gupta, Avinash; Li, Caili; Si, Lu; Ubaldi, Martina; Yamazaki, Naoya; Ogata, Dai; Johnson, Rebecca; Park, Benjamin C.; Jung, Seungyeon; Madonna, Gabriele; Hochherz, Juliane; Umeda, Yoshiyasu; Nakamura, Yasuhiro; Gebhardt, Christoffer; Festino, Lucia; Capone, Mariaelena; Ascierto, Paolo Antonio; Johnson, Douglas B.; Lo, Serigne N.; Long, Georgina L.; Menzies, Alexander M.; Namikawa, Kenjiro; Mandala, Mario; Guo, Jun; Lorigan, Paul; Najjar, Yana G.; Haydon, Andrew; Quaglino, Pietro; Boland, Genevieve M.; Sullivan, Ryan J.; Furness, Andrew J. S.; Plummer, Ruth; Flaherty, Keith T.
errShare
errSave
Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy
err2023-03-08
err8
errOAAI
errBhave, Prachi; Hong, Angela; Lo, Serigne N.; Johnson, Rebecca; Mangana, Johanna; Johnson, Douglas B.; Dulgar, Ozgecan; Eroglu, Zeynep; Yeoh, Hui-Ling; Haydon, Andrew; Lodde, Georg C.; Livingstone, Elisabeth; Khattak, Adnan; Kaehler, Katharina; Hausschild, Axel; McArthur, Grant A.; Menzies, Alexander Maxwell; Long, Georgina; Wang, Wei; Carlino, Matteo S.
errShare
errSave
Adjuvant anti-PD-1 monotherapy benefit varies across different ethnicities and melanoma subtypes
err2022-09-01
err0
errOAAI
errBai, X.; Gerstberger, S.; Park, B.; Jung, S.; Johnson, R.; Yamazaki, N.; Ogata, D.; Umeda, Y.; Li, C.; Si, L.; Flaherty, K.; Nakamura, Y.; Namikawa, K.; Long, G. V.; Menzies, A. M.; Johnson, D. B.; Sullivan, R. J.; Boland, G.; Guo, J.
errShare
errSave
A MULTICENTER CHARACTERIZATION OF CHRONIC TOXICITIES FOLLOWING ADJUVANT ANTI-PD-1 THERAPY FOR HIGH RISK RESECTED MELANOMA
err2020-12-10
err0
PREAI
errPatrinely, James; Johnson, Rebecca; Lawless, Aleigha; Bhave, Prachi; Sawyers, Amelia; Dimitrova, Maya; Yeohc, Hui; Palmeri, Marisa; Davis, Elizabeth; Rapisuwon, Suthee; Long, Georgina; Haydon, Andrew; Osman, Iman; Mehnert, Janice; Carlino, Matteo; Sullivan, Ryan; Menzies, Alexander; Johnson, Douglas
errShare
errSave